Millions of DNA records in Stake as 23andma’s COVERS and CEO files stopped in business
Genetic Giant 23ande test applied for the US defense protection as it intends to sell its business – to put personal genetic data – millions of customers in a pervaded area.
The San Francisco company wakes up the prominence of DNA buyers, announced on Sunday that had invented 11th chapter in Missouri to increase its business value. “
The amazing development follows disaster risk breakfast by 2023 that puts on the personal information of approximately 7 million customers – about half of its worldwide user basis. With a cust trust plumminging and a net income, the company has been on 40 percent of their countrymen, established all medical development, and now supports uncertain future.
In addition to the exile, the Founder and Executive of the Executive Executive Anne Wojcicki decreased to obtain a private bidder – each of which has never been proposed successfully in previous months. You live on the board but have passed the well-being and the day and date of going to Cfo Joe Sel Sales.
The latest of Ntojcicki’s recent supply, informing the firm of $ 11 million, symbolizes a wonderful fall from the type of company once cost 2028.
The company received $ 35 million in dealing with the funds from the JMB Capate Partial Partners to maintain services during sales, and emphasizes that “business as usual”. “No changes along company stores, treat, or protect customer data,” said 23andme.
But worry about genetic products is increasing. California’s lawyer, California’s lawyer, issue a government warning for the weekend to urge the removal of their DNA information and destruction of their living samples. The company already barks $ 30 million and provides three years of protection protection following a case of class action on the violation of the law.
The chairman Mark Jensen said the sale control of the court was the only active route. “Data privacy will be important considerations for any potential transaction,” noted.
Wojcicki, Presentation 23andme in 2006, created the wishes to renew the company to become a drug engineer by putting its great genetic database. This strategy is now in the ice, and all the medical projects of the IDD.
Writing on X (formerly), pointed out the disappointment: “If I am lucky:” If I am well enough to protect company’s belongings through a reconstruction process, I am committed to our long-term leader. “
But critics argue that the fallen 23andome is a solid warning about the risk of selling sensitive health data without sufficient protection. As one of the first components of the directory of consumers.
With their 15 million DNA profiles in their walls and their hands-on ownership, Privacy campaigns and customers look closely – and they want powerful protection where it should be sold.
